UPDATE: Regeneron Pharmaceuticals Posts Downbeat Q4 Earnings, But Sales Top Views
February 10, 2015 at 09:24 AM EST
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) reported weaker-than-expected earnings for the fourth quarter. However, the company ...